Sio Gene Therapies, Inc. (SIOX): Price and Financial Metrics
GET POWR RATINGS... FREE!
SIOX Stock Price Chart Interactive Chart >
SIOX Price/Volume Stats
|Current price||$1.12||52-week high||$3.60|
|Prev. close||$1.09||52-week low||$1.04|
|Day high||$1.15||Avg. volume||421,813|
|50-day MA||$1.41||Dividend yield||N/A|
|200-day MA||$2.05||Market Cap||81.70M|
Sio Gene Therapies, Inc. (SIOX) Company Bio
Sio Gene Therapies, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops gene therapies that transform the treatment of serious neurodegenerative diseases. Sio Gene Therapies serves customers worldwide.
Most Popular Stories View All
SIOX Latest News Stream
|Loading, please wait...|
SIOX Latest Social Stream
View Full SIOX Social Stream
Latest SIOX News From Around the Web
Below are the latest news stories about Sio Gene Therapies Inc that investors may wish to consider to help them evaluate SIOX as an investment opportunity.
Cambridge, MA, based Investment company Opaleye Management Inc. (Current Portfolio) buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics Pharmaceuticals Inc, Amicus Therapeutics Inc, Merus NV, sells ESSA Pharma Inc, Seres Therapeutics Inc, CM Life Sciences Inc, Lumos Pharma Inc, Kezar Life Sciences Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Opaleye Management Inc..
I began my coverage of Sio Gene Therapies (SIOX) in September 2020 noting that the company offered an interesting risk/reward proposition, but at that time I wasn't yet convinced enough to become a shareholder. Since then I've written about the company on two more occasions and became a shareholder in...
Shares of Sio Gene Therapies Inc. (NASDAQ:SIOX) have earned a consensus rating of Buy from the seven brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating and six have issued a buy rating on the company. The average 12 month target price among brokerages 
Sio Gene Therapies Inc. (NASDAQ: SIOX) Has Succeeded To Excite In 2021, The Stock Is Down -49.64% Year-To-Date
Sio Gene Therapies Inc. (NASDAQ:SIOX)s traded shares stood at 0.48 million during the last session, with the companys beta value hitting 1.57. At the close of trading, the stocks price was $1.40, to imply a decrease of -4.11% or -$0.06 in intraday trading. The SIOX shares 52-week high remains $4.15, putting it -196.43% down since Sio Gene Therapies Inc. (NASDAQ: SIOX) Has Succeeded To Excite In 2021, The Stock Is Down -49.64% Year-To-Date Read More »
Sio Gene Therapies Inc. (NASDAQ:SIOX) concluded the trading at $1.41 on Friday, December 03 with a fall of -5.37% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.49 and 5Y monthly beta was reading 1.75 with its price kept floating in New Insight On Sio Gene Therapies Inc. (SIOX) Read More »
SIOX Price Returns